MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients

By Hecker Michael   Thamilarasan Madhan   Koczan Dirk   Schröder Ina   Flechtner Kristin   Freiesleben Sherry   Füllen Georg   Thiesen Hans-Jürgen   Zettl Uwe Klaus  

International Journal of Molecular Sciences, Vol. 14, Iss. 8, 2013-08 ,pp. : 16087-16110

MDPI

Access to resources Recommend Favorite

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells

By Trinschek Bettina   Luessi Felix   Gross Catharina C.   Wiendl Heinz   Jonuleit Helmut  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 16330-16346

MDPI

Access to resources Recommend Favorite

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis

By Kolb-Mäurer Annette   Goebeler Matthias   Mäurer Mathias  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 14951-14960

MDPI

Access to resources Recommend Favorite

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis

By Chiba Kenji   Adachi Kunitomo  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 514-528

MDPI

Access to resources Recommend Favorite

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness

By Ehler Johannes   Blechinger Stephan   Rommer Paulus S.   Koball Sebastian   Mitzner Steffen   Hartung Hans-Peter   Leutmezer Fritz   Sauer Martin   Zettl Uwe K.  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1749-1749

MDPI

Access to resources Recommend Favorite